Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Hickman

Showing results (481-490 of 519) with videos related to

Pageof 52
Sort By:
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
Alcoholism, Clinical and Experimental Research|February 7, 2018
Polygenic Risk Score Prediction of Alcohol Dependence Symptoms Across Population-Based and Clinically Ascertained SamplesJeanne E Savage, Jessica E Salvatore, Fazil Aliev, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
American Journal of Epidemiology|June 1, 2019
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban ComparisonHannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Journal of Viral Hepatitis|November 21, 2024
Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health SurveyGetahun Molla Kassa, Atsbeha Gebreegziabxier Weldemariam, Saro Abdella Abrahim, et al.
Lancet (London, England)|December 1, 2014
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitisRoger Williams, Richard Aspinall, Mark Bellis, et al.
Pageof 52

Showing results (481-490 of 519) with videos related to

Sort By:
Pageof 52
The International Journal on Drug Policy|January 11, 2016
Empfehlungen zur Hepatitis Versorgung bei DrogenkonsumierendenJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
Alcoholism, Clinical and Experimental Research|February 7, 2018
Polygenic Risk Score Prediction of Alcohol Dependence Symptoms Across Population-Based and Clinically Ascertained SamplesJeanne E Savage, Jessica E Salvatore, Fazil Aliev, et al.
The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The International Journal on Drug Policy|February 6, 2016
Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injectionJason Grebely, Geert Robaeys, Philip Bruggmann, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
American Journal of Epidemiology|June 1, 2019
Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban ComparisonHannah Fraser, Claudia Vellozzi, Thomas J Hoerger, et al.
Journal of Viral Hepatitis|November 21, 2024
Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health SurveyGetahun Molla Kassa, Atsbeha Gebreegziabxier Weldemariam, Saro Abdella Abrahim, et al.
Lancet (London, England)|December 1, 2014
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitisRoger Williams, Richard Aspinall, Mark Bellis, et al.
Pageof 52